title: Rituximab with chemotherapy improves survival of non-germinal center type untreated diffuse large B-cell lymphoma.
authors.forename: B
authors.initials: B
authors.lastname: Saito
authors.forename: E
authors.initials: E
authors.lastname: Shiozawa
authors.forename: T
authors.initials: T
authors.lastname: Usui
authors.forename: H
authors.initials: H
authors.lastname: Nakashima
authors.forename: T
authors.initials: T
authors.lastname: Maeda
authors.forename: N
authors.initials: N
authors.lastname: Hattori
authors.forename: J
authors.initials: J
authors.lastname: Shimozuma
authors.forename: D
authors.initials: D
authors.lastname: Adachi
authors.forename: T
authors.initials: T
authors.lastname: Yamochi-Onizuka
authors.forename: M
authors.initials: M
authors.lastname: Takimoto
authors.forename: T
authors.initials: T
authors.lastname: Nakamaki
authors.forename: H
authors.initials: H
authors.lastname: Ota
authors.forename: S
authors.initials: S
authors.lastname: Tomoyasu
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D018572:Disease-Free Survival; D004317:Doxorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives; D004341:Drug Evaluation; D005260:Female; D019254:Genes, bcl-2; D006801:Humans; D007167:Immunotherapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000145:classification / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016328:NF-kappa B / Q000037:antagonists & inhibitors; D011239:Prednisolone / Q000008:administration & dosage; D012189:Retrospective Studies; D000069283:Rituximab; D016019:Survival Analysis; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D016328:NF-kappa B; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; C027260:pirarubicin